PapersPMID:19938054
Oral L-arginine supplementation in acute myocardial infarction therapy: a meta-analysis of randomized controlled trials.
L-arginineNo finding here moved its endpoint.
What did not
1 findingHow to read these marks →- No detected effect on all-cause mortality
very limited
“In an overall pooled estimate, there was a 7% reduction in mortality in the L-arginine treatment group (105/459, 22.9%) compared with the control group (111/455, 24.4%), which did not reach statistical significance (risk ratio [RR]: 0.93, 95% confidence interval [CI]: 0.74-1.17; P = 0.54).”
- Study
- meta-analysis
- Effect
- 0.93 risk ratio, 95% CI 0.74 to 1.17
- Population
- Patients with acute myocardial infarction; pooled randomized placebo-controlled trials (2 trials)
Study record
- Design
- meta-analysis
- Species
- human
- Population
- patients with acute myocardial infarction (AMI); meta-analysis of oral L-arginine versus placebo, free L-arginine
- Participants
- 927
- Comparator
- placebo
- Duration
- not reported
- Endpoints measured
- 2
- Declined
- the paper never states the instrument the node requires